These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4289384)

  • 21. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relation between sudoral excretion of sodium and potassium and the renin-angiotensin-aldosterone system in arterial hypertension].
    Rosset G
    J Urol Nephrol (Paris); 1972; 78(4):345-7. PubMed ID: 4340936
    [No Abstract]   [Full Text] [Related]  

  • 23. [Renin-angiotensin system in hepatic cirrhosis].
    Fiordalisi HH; Mamianetti A
    Acta Gastroenterol Latinoam; 1979; 9(4):225-35. PubMed ID: 399153
    [No Abstract]   [Full Text] [Related]  

  • 24. [Role of the renin-angiotensin-aldosterone system in ascitic hepatic cirrhosis. Effects of inhibition of angiotensin I converting enzyme].
    Santucci A; Aguglia F; De Mattia G; Cammarella I; Trinchieri F; Giordano M; Gnecchi M; Ficara C
    Clin Ter; 1983 Jul; 106(2):121-4. PubMed ID: 6313280
    [No Abstract]   [Full Text] [Related]  

  • 25. [Angiotensin II: its possible role in homeostasis of extracellar fluid volume].
    Agnoli GC; Cariani A; Garutti C; Montini T
    G Clin Med; 1974 Mar; 55(3):161-236. PubMed ID: 4372117
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of renal kallikrein in the derangement of sodium and water excretion in cirrhotic patients.
    Hattori K; Hasumura Y; Takeuchi J
    Scand J Gastroenterol; 1984 Sep; 19(6):844-8. PubMed ID: 6393317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Function of the microcirculation and renin-angiotensin-aldosterone system in liver cirrhosis].
    Nazyrov FG; Khalmuratova RA; Khamidov PM; Saatov RR
    Klin Khir (1962); 1985; (9):31-3. PubMed ID: 3877209
    [No Abstract]   [Full Text] [Related]  

  • 28. [The levels of renin activity, angiotensin converting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt].
    Zhang Z; Feng H; Leng X; Ma F; Wang B; Du R
    Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):366-8. PubMed ID: 11829864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Some aspects of the action of angiotensin on the kidney].
    Jahn H; Reville P; Kurtz T; Kuntzmann F; Stahl J
    Pathol Biol; 1967; 15(11):641-8. PubMed ID: 4292970
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mechanisms of renal retention of sodium and water in heart failure, cirrhosis and pregnancy].
    Knotek M; Rogachev B; Ohara M; Schrier RW
    Lijec Vjesn; 2000; 122(1-2):20-6. PubMed ID: 10916353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of aldosterone and angiotensin on renal function.
    Louis WJ; Doyle AE
    Clin Sci; 1966 Apr; 30(2):179-89. PubMed ID: 4287511
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the urinary excretion of aldosterone. II. On the role of aldosterone in the pathogenesis of some clinical syndromes].
    DE MARTINIS C; FONZO D
    Folia Endocrinol Mens Incretologia Incretoterapia; 1962 Jun; 15():316-37. PubMed ID: 14025920
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inhibition of natriuretic effect of angiotensin by spirolactones and salidiuretics in cirrhosis and arterial hypertension].
    Kuntzmann F; Reville P; Kurtz T; Jahn H; Stahl J
    Pathol Biol (Paris); 1969 May; 17(9):447-58. PubMed ID: 4308377
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of dipyridamole on kidney function in cirrhosis.
    Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
    Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renin angiotensin system and liver fibrosis or cirrhosis].
    Shen FJ; Yin CH; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):447-8. PubMed ID: 12890362
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pathogenesis and treatment of the edema-ascites syndrome in patients with cirrhosis of the liver].
    Loginov AS; Berezov VM
    Ter Arkh; 1967 Aug; 39(8):12-20. PubMed ID: 4890954
    [No Abstract]   [Full Text] [Related]  

  • 37. Renin, aldosterone, and hypertension. The hepatic metabolism of renin and aldosterone. A review with new observations on the hepatic clearance of renin.
    Schneider EG; Davis JO; Baumber JS; Johnson JA
    Circ Res; 1970 Jul; 27(1 Suppl 1):175-83. PubMed ID: 5423297
    [No Abstract]   [Full Text] [Related]  

  • 38. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
    Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
    Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
    Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.